Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Assembly Biosciences (ASMB) stocks in Canada

Learn how to easily invest in Assembly Biosciences stocks.

Assembly Biosciences is a biotechnology business based in the US. Assembly Biosciences stocks (ASMB.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.1 – a decrease of 2.27% over the previous week. Assembly Biosciences employs 139 staff and has a trailing 12-month revenue of around $7.3 million.

How to buy shares in Assembly Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ASMB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Assembly Biosciences stock price (NASDAQ:ASMB)

Use our graph to track the performance of ASMB stocks over time.

Assembly Biosciences shares at a glance

Information last updated 2022-01-23.
Latest market close$1.72
52-week range$1.58 - $7.02
50-day moving average $2.26
200-day moving average $3.32
Wall St. target price$10.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.66

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Assembly Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Assembly Biosciences price performance over time

Historical closes compared with the close of $1.72 from 2022-01-26

1 week (2022-01-20) -2.27%
1 month (2021-12-24) N/A
3 months (2021-10-27) -44.52%
6 months (2021-07-28) -51.96%
1 year (2021-01-28) -69.12%
2 years (2020-01-28) -89.76%
3 years (2019-01-28) 21.06
5 years (2017-01-27) 18.98

Assembly Biosciences financials

Revenue TTM $7.3 million
Gross profit TTM $-22,232,000
Return on assets TTM -24.76%
Return on equity TTM -44.03%
Profit margin 0%
Book value $4.77
Market capitalisation $81.4 million

TTM: trailing 12 months

Assembly Biosciences share dividends

We're not expecting Assembly Biosciences to pay a dividend over the next 12 months.

Have Assembly Biosciences's shares ever split?

Assembly Biosciences's shares were split on a 1:5 basis on 13 July 2014. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Assembly Biosciences shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Assembly Biosciences shares which in turn could have impacted Assembly Biosciences's share price.

Assembly Biosciences share price volatility

Over the last 12 months, Assembly Biosciences's shares have ranged in value from as little as $1.58 up to $7.02. A popular way to gauge a stock's volatility is its "beta".

ASMB.US volatility(beta: 0.66)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assembly Biosciences's is 0.6624. This would suggest that Assembly Biosciences's shares are less volatile than average (for this exchange).

Assembly Biosciences overview

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd. ; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. It also has a clinical collaboration agreement with Antios Therapeutics, Inc.

Stocks similar to Assembly Biosciences

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site